DGAP-Adhoc: Ad Hoc Announcement pursuant to Sec. 15 WpHG

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

May 11, 2015 at 2:45 AM

DGAP-Adhoc: Ad Hoc Announcement pursuant to Sec. 15 WpHG (German Securities Trading Act): Epigenomics AG Announces Capital Increase up to EUR 5M

Epigenomics AG / Key word(s): Capital Increase/Miscellaneous 11.05.2015 08:38 Dissemination of an Ad hoc announcement according to Â§ 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Not for distribution in the United States of America Berlin, Germany, May 11, 2015 - Today the Executive Board of Epigenomics AG, Berlin, Germany (Frankfurt Prime Standard: ECX; ISIN: DE000A11QW50), with the approval of the Supervisory Board, resolved to partially exercise its authorization under the Company's Authorized Capital 2014/II and to increase the Company's issued share capital against cash contributions from currently EUR 16,092,197.00 by up to EUR 976,562 up to EUR 17,068,759 by issuing up to 976,562 new ordinary registered shares with no-par value, each such share representing a notional nominal amount of the issued share capital of EUR 1.00 per share. The new shares will be issued at a subscription price of EUR 5.12 per new share and will carry full dividend rights as from January 1, 2015. The capital increase is conducted by way of rights issue. The new shares will be offered to the Company's shareholders at a subscription ratio of 33:2, i.e. the Company's shareholders may subscribe for each 33 existing shares 2 new shares. In addition, the shareholders will be offered the possibility to subscribe for additional shares (oversubscription). The subscription offer is expected to be published on the Company's website (www.epigenomics.com) and in the German Federal Gazette (Bundesanzeiger) on May 13, 2015. The subscription period for the Company's shareholders is expected to begin on May 13, 2015 and to end on May 27, 2015 (in each case including such dates). No trading in subscription rights will be organized. Shares not subscribed for by shareholders might subsequently be offered in a private placement to institutional investors subject to selling restrictions as may be applicable in certain jurisdictions. The actual number of new shares eventually issued in, and the final amount of, the capital increase is determined following the end of the subscription period and the take up under the private placement; it will be announced by a separate ad-hoc announcement. The capital increase is structured in a manner that the gross proceeds generated by it will at a maximum be equal to an amount just short of EUR 5,000,000.00, but will not reach that amount, so that the capital increase does not require a prospectus under German law. The amount of the gross proceeds actually generated depends on the number of new shares eventually subscribed for or taken up under the private placement and may therefore fall more or less short of the envisaged maximum amount. Epigenomics AG intends to use the net proceeds from the offering to finance certain market introductory measures for Epi proColon(R) in the US, to strengthen its manufacturing capabilities as well as to build product inventory and lastly to finance its current business operations. - End of Ad hoc - Disclaimer This publication is not an offer of any securities for sale or a solicitation of an offer to purchase any securities. This document is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States of America. The shares of Epigenomics AG (the "Shares") have not been registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States unless registered under the Securities Act or pursuant to an exemption from such registration. There will be no public offering of the Shares in the United States and the Shares will not be registered under the Securities Act. Contact: Epigenomics AG Antje Zeise CIRO Manager IR | PR Epigenomics AG Phone: +49 (0) 30 24345 386 ir@epigenomics.com www.epigenomics.com 11.05.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Epigenomics AG GeneststraÃe 5 10829 Berlin Germany Phone: +49 30 24345-0 Fax: +49 30 24345-555 E-mail: ir@epigenomics.com Internet: www.epigenomics.com ISIN: DE000A11QW50 WKN: A11QW5 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BULL Faces Class Action After Regulatory Fines

Webull's Financial Quake Shakes Investors You don't expect to wake up to news of a stock in freefall, but here we are with Webull (NASDAQ:BULL) cratering after some rough compliance problems came to light. On November 5, 2026, Webull's stock tumbled nearly 11% thanks to FINRA slapping them with a $4.2 million fine for failing to keep their anti-money laundering (AML) and...

GTEC Faces Nasdaq Bid Price Compliance Challenge

Greenland Technologies in a Tight Spot Man, stocks can be as unpredictable as a cat on a hot tin roof, and Greenland Technologies Holding Corporation (Nasdaq: GTEC) just got a cold splash of reality from Nasdaq. On November 10, 2026, they were handed a Notification Letter that ain’t exactly a love note. Their shares slipped below the one-buck hurdle, and Nasdaq isn’t...

U-wifi Gains Charlie Vogt: Key Steps in 5G Expansion

Charlie Vogt Joins U-wifi: A Broadband Game Changer? There's a new player in town shaking things up, and he's no rookie. Charlie Vogt, five-time technology CEO and Managing Director at Bowen, is hopping onto U-wifi's board of directors. This isn't just about another corporate announcement; it's like adding a veteran quarterback to your expansion team. Vogt’s pedigree in...

Partner Joins Yardi ICN, Boosting Data Quality for Clients

Strategic Alliances in Real Estate Data When Partner Engineering and Science, Inc. says they're hooking up with the Yardi Independent Consultant Network (ICN), that's not just some boardroom handshake. It's a play that could shake up data services in the real estate game. Look, there's plenty of chatter about digitizing property management, but without killer data, those...

Choosing Screen-Free Outdoor Gifts: besrey's Top Picks

The Art of Choosing Outdoor Gifts for Kids Christmas time, my friends, isn't just about plastic gimmicks and gadgets vying for kids' attention. Nope, it's about making thoughtful decisions that blend discovery, movement, and a little peace of mind for parents. This time around, besrey's got the scoop on screen-free gifts that might just do the trick—helping kids explore...

SAHZU Hospital Earns GHA Distinction for Travel Care

A New Benchmark in International Patient Experience When a hospital sets the standard for treating foreign patients like family, it deserves recognition. That's exactly what's happened at The Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU), which just snagged an impressive accolade from Global Healthcare Accreditation (GHA). For anyone keeping...

Cemig and Huawei's Bold Network Leap: Power Up

By Ryan Hughes Updated Nov 13, 2026 Category News Views 100

Taking the Leap in Brazil's Power Grid In Brazil, energy distribution's a whole different beast, and boy, is it complicated! Cemig found out the hard way that relying on public networks was a risky bet. Consistently bad. With a measly 50% coverage in Brazil's vast lands, you're looking at a communications nightmare, especially in the back of beyond where grid faults could...

Revolutionary Sports Ball Backpack: A Game Changer?

Backpacks Reinvented by a Clever Mom Ever been caught in the whirlwind of juggling kids, sports gear, and school supplies? Well, one stay-at-home mom from Poway, California found herself in just such a predicament. She turned this everyday chaos into a creative solution by designing a unique Sports Ball Backpack. The idea came to her while managing a toddler, a newborn,...

DEEPBLUE's Panelized Systems Target Low-Rise Markets

Changing the Game in Low-Rise Construction Been around the block a few times and seen all sorts of hype in this industry, but what DEEPBLUE SMARTHOUSE is pushing sounds more like evolution than revolution for low-rise builds. They're leaning into this panelized building system like a boxer on the ropes—that's their strategy to keep things steady and predictable. The...

DraftKings Shares Tumble, Investors Grapple with Losses

DraftKings' Bold Moves Hit Investor Pockets Hard It ain't every day you see a company gamble nearly $700 million and come out with egg on its face. Yet, that's what DraftKings (NASDAQ: DKNG) seems to have done, and now it's shareholders who might be left holding the bag. On November 6, 2026, when DraftKings admitted it was doubling down on its Predictions business...